Exploring ZPLD1 as a Prognostic Indicator and Therapeutic Target in Bladder Cancer

This study establishes ZPLD1 as a prognostic indicator and potential therapeutic target in BLCA, paving the way for precision oncology strategies integrating ZPLD1-guided patient selection and immune-drug combinations.

Authors

Guodong Ding
Yiwen Chen (ORCID: https://orcid.org/0009-0003-8102-7191)
Hanliang Zhu
Dongbing Li
Meiting Lao
Youwei Yue
Wangdong Deng

Institutions

Soochow University (CN)
Longgang Central Hospital (CN)

Publication Details

Journal: Current Medicinal Chemistry
Published: 2026-01-15
DOI: https://doi.org/10.2174/0109298673413898251122184011
Primary Topic: Bladder and Urothelial Cancer Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Exploring ZPLD1 as a Prognostic Indicator and Therapeutic Target in Bladder Cancer

Guodong Ding, Yiwen Chen, Hanliang Zhu, Dongbing Li et al.

Jan 15, 2026

Current Medicinal Chemistry

Bladder and Urothelial Cancer Treatments

article

Exploring ZPLD1 as a Prognostic Indicator and Therapeutic Target in Bladder Cancer

Guodong Ding, Yiwen Chen, Hanliang Zhu, Dongbing Li, Meiting Lao, Youwei Yue, Wangdong Deng

January 15, 2026article en

Abstract

Current Medicinal ChemistryVol. 33

Soochow University (CN), Longgang Central Hospital (CN)

Good health and well-being

Openalex Percentile: Top 77%

Bladder and Urothelial Cancer Treatments

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.